Literature DB >> 24476133

Inactivation of AKT induces cellular senescence in uterine leiomyoma.

Xiaofei Xu1, Zhenxiao Lu, Wenan Qiang, Vania Vidimar, Beihua Kong, J Julie Kim, Jian-Jun Wei.   

Abstract

Uterine leiomyomas (fibroids) are a major public health problem. Current medical treatments with GnRH analogs do not provide long-term benefit. Thus, permanent shrinkage or inhibition of fibroid growth via medical means remains a challenge. The AKT pathway is a major growth and survival pathway for fibroids. We propose that AKT inhibition results in a transient regulation of specific mechanisms that ultimately drive cells into cellular senescence or cell death. In this study, we investigated specific mechanisms of AKT inhibition that resulted in senescence. We observed that administration of MK-2206, an allosteric AKT inhibitor, increased levels of reactive oxygen species, up-regulated the microRNA miR-182 and several senescence-associated genes (including p16, p53, p21, and β-galactosidase), and drove leiomyoma cells into stress-induced premature senescence (SIPS). Moreover, induction of SIPS was mediated by HMGA2, which colocalized to senescence-associated heterochromatin foci. This study provides a conceivable molecular mechanism of SIPS by AKT inhibition in fibroids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24476133      PMCID: PMC3959594          DOI: 10.1210/en.2013-1929

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  37 in total

1.  MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.

Authors:  Elizabeth C Sefton; Wenan Qiang; Vanida Serna; Takeshi Kurita; Jian-Jun Wei; Debabrata Chakravarti; J Julie Kim
Journal:  Endocrinology       Date:  2013-09-03       Impact factor: 4.736

2.  HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway.

Authors:  Kyung-Rok Yu; Sang-Bum Park; Ji-Won Jung; Min-Soo Seo; In-Sun Hong; Hyung-Sik Kim; Yoojin Seo; Tae-Wook Kang; Jin Young Lee; Andreas Kurtz; Kyung-Sun Kang
Journal:  Stem Cell Res       Date:  2012-11-16       Impact factor: 2.020

3.  p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.

Authors:  Dominique Nadine Markowski; Nina Winter; Frauke Meyer; Inga von Ahsen; Heiner Wenk; Ingo Nolte; Jörn Bullerdiek
Journal:  Genes Chromosomes Cancer       Date:  2011-03-31       Impact factor: 5.006

4.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

5.  Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.

Authors:  Jieru Meng; Bingbing Dai; Bingliang Fang; B Nebiyou Bekele; William G Bornmann; Duoli Sun; Zhenghong Peng; Roy S Herbst; Vassiliki Papadimitrakopoulou; John D Minna; Michael Peyton; Jack A Roth
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

6.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

7.  Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.

Authors:  Judy S Crabtree; Scott A Jelinsky; Heather A Harris; Sung E Choe; Monette M Cotreau; Michelle L Kimberland; Ewa Wilson; Kathryn A Saraf; Wei Liu; Adrienne S McCampbell; Bhuvanesh Dave; Russell R Broaddus; Eugene L Brown; Wenling Kao; Jerauld S Skotnicki; Magid Abou-Gharbia; Richard C Winneker; Cheryl L Walker
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

8.  Cellular senescence in usual type uterine leiomyoma.

Authors:  Jordan Laser; Peng Lee; Jian-Jun Wei
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

9.  Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.

Authors:  Lan Peng; Yong Wen; Yulong Han; Anran Wei; Guizhi Shi; Masashi Mizuguchi; Peng Lee; Eva Hernando; Khush Mittal; Jian-Jun Wei
Journal:  Fertil Steril       Date:  2008-04-25       Impact factor: 7.329

10.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

Authors:  Patryk Moskwa; Francesca M Buffa; Yunfeng Pan; Rohit Panchakshari; Ponnari Gottipati; Ruth J Muschel; John Beech; Ritu Kulshrestha; Kotb Abdelmohsen; David M Weinstock; Myriam Gorospe; Adrian L Harris; Thomas Helleday; Dipanjan Chowdhury
Journal:  Mol Cell       Date:  2010-12-30       Impact factor: 17.970

View more
  15 in total

1.  Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.

Authors:  Jia Xie; Julianne Ubango; Yanli Ban; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2018-08-20       Impact factor: 5.006

2.  Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma.

Authors:  Xiuhua Xu; J Julie Kim; Yinuo Li; Jia Xie; Changshun Shao; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2018-08-10       Impact factor: 4.599

3.  Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer.

Authors:  Qiulan Chen; Lanju Yang; Yilei Xiao; Jianxin Zhu; Zhongmin Li
Journal:  Med Oncol       Date:  2014-10-19       Impact factor: 3.064

4.  The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model.

Authors:  Vania Vidimar; Debabrata Chakravarti; Serdar E Bulun; Ping Yin; Romana Nowak; Jian-Jun Wei; J Julie Kim
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

5.  Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function.

Authors:  Shimeng Liu; Ping Yin; Ariel J Dotts; Stacy A Kujawa; John S Coon V; Jian-Jun Wei; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2020-09-04       Impact factor: 7.329

6.  MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.

Authors:  Dachun Xiao; Jian Xie; Shuai Wu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 7.  Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities.

Authors:  Malak El Sabeh; Subbroto Kumar Saha; Sadia Afrin; Md Soriful Islam; Mostafa A Borahay
Journal:  Mol Cell Biochem       Date:  2021-05-17       Impact factor: 3.842

Review 8.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

9.  Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells.

Authors:  Yugang Liu; Wenan Qiang; Xiaofei Xu; Ruifen Dong; Alison M Karst; Zhaojian Liu; Beihua Kong; Ronny I Drapkin; Jian-Jun Wei
Journal:  Oncotarget       Date:  2015-11-17

10.  Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas.

Authors:  Vania Vidimar; David Gius; Debabrata Chakravarti; Serdar E Bulun; Jian-Jun Wei; J Julie Kim
Journal:  Sci Adv       Date:  2016-11-04       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.